Trial Profile
Acute Impact of IM Aripiprazole and Olanzapine on Insulin Resistance in High Risk Prediabetics
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Dec 2012
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Olanzapine (Primary)
- Indications Aggression; Bipolar disorders; Depressive disorders; Gilles de la Tourette's syndrome; Manic episodes; Schizophrenia
- Focus Pharmacodynamics
- 11 Aug 2011 New trial record